Evidence map›Paper›PMID 23576723›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function.

Björn Tews, Kai Schönig, Michael E Arzt, Stefano Clementi, Mengia-Seraina Rioult-Pedotti, Ajmal Zemmar, Stefan M Berger, Miriam Schneider, Thomas Enkel, Oliver Weinmann and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Experimental pediatric stroke shows age-specific recovery of cognition and role of hippocampal Nogo-A receptor signaling.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain.Journal of neurology and experimental neuroscience · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Acquisition of a High-precision Skilled Forelimb Reaching Task in Rats.Journal of visualized experiments : JoVE · 2015
    Article
  19. Article
  20. Function of Nogo-A/Nogo-A receptor in Alzheimer's disease.CNS neuroscience & therapeutics · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Björn TewsBrain Research Institute, University of Zürich and Department of Health Sciences and Technology, Eidgenössiche Technische Hochschule, Switzerland, 8057 Zürich, Switzerland.
Kai Schönig
Michael E Arzt
Stefano Clementi
Mengia-Seraina Rioult-Pedotti
Ajmal Zemmar
Stefan M Berger
Miriam Schneider
Thomas Enkel
Oliver Weinmann
Hansjörg Kasper
Martin E Schwab
Dusan Bartsch
University of Zurich · CHCentral Institute of Mental Health · DEHeidelberg University · DEBrown University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have generated a transgenic rat model using RNAi and used it to study the role of the membrane protein Nogo-A in synaptic plasticity and cognition. The membrane protein Nogo-A is expressed in CNS oligodendrocytes and subpopulations of neurons, and it is known to suppress neurite growth and regeneration. The constitutively expressed polymerase II-driven transgene was composed of a microRNA-targeting Nogo-A placed into an intron preceding the coding sequence for EGFP, thus quantitatively labeling cells according to intracellular microRNA expression. The transgenic microRNA in vivo efficiently reduced the concentration of Nogo-A mRNA and protein preferentially in neurons. The resulting significant increase in long-term potentiation in both hippocampus and motor cortex indicates a repressor function of Nogo-A in synaptic plasticity. The transgenic rats exhibited prominent schizophrenia-like behavioral phenotypes, such as perseveration, disrupted prepulse inhibition, and strong withdrawal from social interactions. This fast and efficient microRNA-mediated knockdown provides a way to silence gene expression in vivo in transgenic rats and shows a role of Nogo-A in regulating higher cognitive brain functions.

Indexed as

AnimalsCognitionGene Expression RegulationGreen Fluorescent ProteinsLong-Term PotentiationMicroRNAsMyelin ProteinsNeuronal PlasticityNogo ProteinsRatsRats, TransgenicRNA InterferenceSynapsesTransgenesenhanced green fluorescent proteinGreen Fluorescent ProteinsMicroRNAsMyelin ProteinsNogo ProteinsRtn4 protein, rat

Identifiers

PMID23576723
PMCPMC3631667
OpenAlexW2026883273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.